Abstract No: 8594
Background: Carfilzomib (CFZ) is a selective proteasome inhibitor approved in the US for the treatment of relapsed … Article
Abstract No: 8594
Background: Carfilzomib (CFZ) is a selective proteasome inhibitor approved in the US for the treatment of relapsed … Article
June 23, 2014
0 Comments